These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 593269)

  • 21. The location of drug binding sites in human serum albumin.
    Fehske KJ; Müller WE; Wollert U
    Biochem Pharmacol; 1981 Apr; 30(7):687-92. PubMed ID: 7018498
    [No Abstract]   [Full Text] [Related]  

  • 22. [Fast liquid chromatographic method to determine compounds binding to human serum albumin].
    Valkó K
    Acta Pharm Hung; 2003; 73(1):13-22. PubMed ID: 12891895
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chain length-dependent binding of fatty acid anions to human serum albumin studied by site-directed mutagenesis.
    Kragh-Hansen U; Watanabe H; Nakajou K; Iwao Y; Otagiri M
    J Mol Biol; 2006 Oct; 363(3):702-12. PubMed ID: 16979183
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug therapy. Serum drug concentrations as therapeutic guides.
    Koch-Weser J
    N Engl J Med; 1972 Aug; 287(5):227-31. PubMed ID: 5037497
    [No Abstract]   [Full Text] [Related]  

  • 25. Binding of drugs to serum albumin (first of two parts).
    Koch-Weser J; Sellers EM
    N Engl J Med; 1976 Feb; 294(6):311-6. PubMed ID: 1107839
    [No Abstract]   [Full Text] [Related]  

  • 26. Molecular dynamics study of conformational changes in human serum albumin by binding of fatty acids.
    Fujiwara S; Amisaki T
    Proteins; 2006 Aug; 64(3):730-9. PubMed ID: 16783783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determination of drug-plasma protein binding using human serum albumin chromatographic column and multiple linear regression model.
    Beaudry F; Coutu M; Brown NK
    Biomed Chromatogr; 1999 Oct; 13(6):401-6. PubMed ID: 10477897
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Concentration-dependent effects of fatty acids on warfarin binding to albumin.
    Wilding G; Feldhoff RC; Vesell ES
    Biochem Pharmacol; 1977 Jun; 26(12):1143-6. PubMed ID: 560850
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of endogenous metabolites on the binding of o-methyl red to human serum albumin [proceedings].
    Bowmer CJ; Lindup WE
    Br J Pharmacol; 1976 Oct; 58(2):283P-284P. PubMed ID: 974403
    [No Abstract]   [Full Text] [Related]  

  • 30. Steroid-protein interactions. 40. The effect of fatty acids on progesterone binding to human serum albumin.
    Ramsey BL; Westphal U
    Biochim Biophys Acta; 1978 Apr; 529(1):115-22. PubMed ID: 638175
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of free fatty acid concentration on drug binding to plasma albumin.
    Spector AA; Santos EC; Ashbrook JD; Fletcher JE
    Ann N Y Acad Sci; 1973 Nov; 226():247-58. PubMed ID: 4520396
    [No Abstract]   [Full Text] [Related]  

  • 32. Increasing excretion of urate with displacing agents in man.
    Whitehouse MW; Kippen I; Klinenberg JR; Schlosstein L; Campion DS; Bluestone R
    Ann N Y Acad Sci; 1973 Nov; 226():309-18. PubMed ID: 4520399
    [No Abstract]   [Full Text] [Related]  

  • 33. New fluorescence probes for drug-albumin interaction studies.
    Goya S; Takadate A; Fujino H; Otagiri M; Uekama K
    Chem Pharm Bull (Tokyo); 1982 Apr; 30(4):1363-9. PubMed ID: 7105256
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of fatty acids on human serum albumin binding centers.
    Dobretsov GE; Syrejshchikova TI; Smolina NV; Uzbekov MG
    Bull Exp Biol Med; 2012 Jul; 153(3):323-6. PubMed ID: 22866302
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 5-(dimethylamino)naphthalene-1-sulfonic acid, a fluorescent probe of the medium chain fatty acid binding site of serum albumin.
    Doody MC; Gotto AM; Smith LC
    Biochemistry; 1982 Jan; 21(1):28-33. PubMed ID: 7059578
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Binding of certain acidic drugs to human albumin: theoretical and practical estimation of fundamental parameters.
    Tillement JP; Zini R; d' Athis P; Vassent G
    Eur J Clin Pharmacol; 1974 Jul; 7(4):307-13. PubMed ID: 4850753
    [No Abstract]   [Full Text] [Related]  

  • 37. Dependence of drug-protein binding parameters on human serum and albumin concentration.
    Brunner F; Zini R; Tillement JP
    J Pharm Pharmacol; 1983 Aug; 35(8):526-8. PubMed ID: 6137542
    [No Abstract]   [Full Text] [Related]  

  • 38. The classification of drugs on the basis of the drug-binding site on human serum albumin.
    Iwatsuru M; Nishigori H; Maruyama K
    Chem Pharm Bull (Tokyo); 1982 Dec; 30(12):4489-93. PubMed ID: 7168873
    [No Abstract]   [Full Text] [Related]  

  • 39. Serum Albumin, Lipid and Drug Binding.
    Nishi K; Yamasaki K; Otagiri M
    Subcell Biochem; 2020; 94():383-397. PubMed ID: 32189308
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural basis of binding of fluorescent, site-specific dansylated amino acids to human serum albumin.
    Ryan AJ; Ghuman J; Zunszain PA; Chung CW; Curry S
    J Struct Biol; 2011 Apr; 174(1):84-91. PubMed ID: 20940056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.